内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2016 PES指南：生长激素缺乏，特发性矮小症和原发性胰岛素样生长因子缺乏儿童和青少年应用生长激素和胰岛素样生长因子1治疗

2016-11-25 儿科内分泌学会 Horm Res Paediatr. 2016 Nov 25.

生长激素缺乏特发性矮小症原发性胰岛素样生长因子缺乏

2016年11月，儿科内分泌学会(PES)发布了生长激素缺乏，特发性矮小症和原发性胰岛素样生长因子缺乏儿童和青少年应用生长激素和胰岛素样生长因子1治疗指南。该指南为由于生长激素缺乏，特发性矮小症和原发性原发性胰岛素样生长因子缺乏导致生长障碍的儿童和青少年的临床管理提供指导建议。

中文标题：

2016 PES指南：生长激素缺乏，特发性矮小症和原发性胰岛素样生长因子缺乏儿童和青少年应用生长激素和胰岛素样生长因子1治疗

英文标题：

Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency.

发布机构：

儿科内分泌学会

发布日期：

2016-11-25

简要介绍：

2016年11月，儿科内分泌学会(PES)发布了生长激素缺乏，特发性矮小症和原发性胰岛素样生长因子缺乏儿童和青少年应用生长激素和胰岛素样生长因子1治疗指南。该指南为由于生长激素缺乏，特发性矮小症和原发性原发性胰岛素样生长因子缺乏导致生长障碍的儿童和青少年的临床管理提供指导建议。

拓展指南：与生长激素缺乏相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 PES指南：生长激素缺乏，特发性矮小症和原发性胰岛素样生长因子缺乏儿童和青少年应用生长激素和胰岛素样生长因子1治疗)] GetToolGuiderByIdResponse(projectId=1, id=14c1d1c0013a65ca, title=2016 PES指南：生长激素缺乏，特发性矮小症和原发性胰岛素样生长因子缺乏儿童和青少年应用生长激素和胰岛素样生长因子1治疗, enTitle=Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency., guiderFrom=Horm Res Paediatr. 2016 Nov 25., authorId=null, author=, summary=2016年11月，儿科内分泌学会(PES)发布了生长激素缺乏，特发性矮小症和原发性胰岛素样生长因子缺乏儿童和青少年应用生长激素和胰岛素样生长因子1治疗指南。该指南为由于生长激素缺乏，特发性矮小症和原发性原发性胰岛素样生长因子缺乏导致生长障碍的儿童和青少年的临床管理提供指导建议。, cover=, journalId=null, articlesId=null, associationId=1337, associationName=儿科内分泌学会, associationIntro=, copyright=0, guiderPublishedTime=Fri Nov 25 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=2016年11月，儿科内分泌学会(PES)发布了生长激素缺乏，特发性矮小症和原发性胰岛素样生长因子缺乏儿童和青少年应用生长激素和胰岛素样生长因子1治疗指南。该指南为由于生长激素缺乏，特发性矮小症和原发性原发性胰岛素样生长因子缺乏导致生长障碍的儿童和青少年的临床管理提供指导建议。<br> <br> 拓展指南：<strong>与<font color=red>生长激素缺乏</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=14c1d1c0013a65ca" title="2016 PES指南：生长激素缺乏，特发性矮小症和原发性胰岛素样生长因子缺乏儿童和青少年应用生长激素和胰岛素样生长因子1治疗" target=_blank>2016 PES指南：生长激素缺乏，特发性矮小症和原发性胰岛素样生长因子缺乏儿童和青少年应用生长激素和胰岛素样生长因子1治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=77fc11c0008119e8" title="成人生长激素缺乏症的评估和治疗：内分泌学会临床实践指南" target=_blank>成人生长激素缺乏症的评估和治疗：内分泌学会临床实践指南</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E7%94%9F%E9%95%BF%E6%BF%80%E7%B4%A0%E7%BC%BA%E4%B9%8F" target=_blank>有关生长激素缺乏更多指南</a></ul>, tagList=[TagDto(tagId=44784, tagName=生长激素缺乏), TagDto(tagId=101002, tagName=特发性矮小症), TagDto(tagId=101003, tagName=原发性胰岛素样生长因子缺乏)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6969, appHits=821, showAppHits=9, pcHits=4685, showPcHits=2780, likes=154, shares=23, comments=5, approvalStatus=1, publishedTime=Sun Jan 01 21:09:22 CST 2017, publishedTimeString=2016-11-25, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Sun Jan 01 21:09:22 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 09:59:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 PES指南：生长激素缺乏，特发性矮小症和原发性胰岛素样生长因子缺乏儿童和青少年应用生长激素和胰岛素样生长因子1治疗)])
2016 PES指南：生长激素缺乏，特发性矮小症和原发性胰岛素样生长因子缺乏儿童和青少年应用生长激素和胰岛素样生长因子1治疗
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1060899, encodeId=dbc51060899eb, content=我来学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dd45631214, createdName=ms9000000252636362, createdTime=Sat Oct 16 02:19:16 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168573, encodeId=b8001685e31a, content=很好，不错的指南资料，值得拥有值得收藏，值得探究。给自己学习探究提供方便。点个赞！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jan 07 12:19:48 CST 2017, time=2017-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167318, encodeId=40bd16e3189d, content=学习啦，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Sun Jan 01 23:05:54 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2021-10-16 ms9000000252636362

    我来学习一下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1060899, encodeId=dbc51060899eb, content=我来学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dd45631214, createdName=ms9000000252636362, createdTime=Sat Oct 16 02:19:16 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168573, encodeId=b8001685e31a, content=很好，不错的指南资料，值得拥有值得收藏，值得探究。给自己学习探究提供方便。点个赞！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jan 07 12:19:48 CST 2017, time=2017-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167318, encodeId=40bd16e3189d, content=学习啦，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Sun Jan 01 23:05:54 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2017-01-07 ylzr123

    很好，不错的指南资料，值得拥有值得收藏，值得探究。给自己学习探究提供方便。点个赞！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1060899, encodeId=dbc51060899eb, content=我来学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dd45631214, createdName=ms9000000252636362, createdTime=Sat Oct 16 02:19:16 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=168573, encodeId=b8001685e31a, content=很好，不错的指南资料，值得拥有值得收藏，值得探究。给自己学习探究提供方便。点个赞！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jan 07 12:19:48 CST 2017, time=2017-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167318, encodeId=40bd16e3189d, content=学习啦，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/12/31/60fc0213ae09a3dbbba19993663ef4db.jpg, createdBy=33c31971480, createdName=1e160a78m83(暂无匿称), createdTime=Sun Jan 01 23:05:54 CST 2017, time=2017-01-01, status=1, ipAttribution=)]
    2017-01-01 1e160a78m83(暂无匿称)

    学习啦，谢谢分享

    0